The Interplay Between Histone Mutations and Replication Stress in Shaping Glioma Phenotypes |
Dana-Farber Cancer Institute / Pratiti Bandopadhayay, PhD |
'A' Award Grants |
2021 |
Massachusetts |
Social Determinants of Health, Hospital-level Resources, and Risk of Septic Shock in Pediatric Leukemia |
Children's Hospital of Philadelphia / Jenny Ruiz, MD |
Young Investigator Grants |
2021 |
Pennsylvania |
Circulating Tumor Biomarkers: New Paradigms for Management of Neuroblastoma |
University of Chicago / Mark Applebaum, PhD |
'A' Award Grants |
2021 |
Illinois |
Dissecting Functional uORFs as a Source of Cancer Genes in High-Risk Medulloblastoma |
Dana-Farber Cancer Institute / John Prensner, MD/PhD |
Young Investigator Grants |
2021 |
Massachusetts |
Turning Killers into THINKers: TME Hostility-Impervious NK Cells for Treating Neuroblastoma and Sarcoma |
Baylor College of Medicine / Robin Parihar, MD/PhD |
'A' Award Grants |
2021 |
Texas |
Dissecting the Contribution and Inheritance of Germline DNA Damage Repair Gene Mutations in Neuroblastoma |
Dana-Farber Cancer Institute / Riaz Gillani, MD |
Young Investigator Grants |
2021 |
Massachusetts |
Role of PHF6 Mutations in Germline RUNX1 Deficiency Associated Hematopoietic Disorders |
Boston Children's Hospital / Serine Avagyan, MD/PhD |
RUNX1 Early Career Investigator Grants |
2021 |
Massachusetts |
Exploiting the Potential of Bromodomain Inhibitors in Ewing Sarcoma |
Seattle Children's Hospital / Shireen Ganapathi, MD |
Young Investigator Grants |
2021 |
Washington |
The Role of LIN28B-let-7-PBK Axis on the Growth and Metastasis of Group 3 Medulloblastoma |
Emory University / Shubin Shahab, MD/PhD |
Young Investigator Grants |
2021 |
Georgia |
GD2-directed CAR T cell therapy for H3K27M+ spinal cord diffuse midline glioma |
Board of Trustees of the Leland Stanford Junior University / Michelle Monje |
Catalyst Grants |
2021 |
California |